| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.079 | 0.07 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.08 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.08 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.08 |